Abbott Laboratories (ABT) Current Deferred Tax Assets (2009 - 2014)

Abbott Laboratories (ABT) has 6 years of Current Deferred Tax Assets data on file, last reported at $1.7 billion in Q4 2014.

• For the quarter ending Q4 2014, Current Deferred Tax Assets fell 32.56% year-over-year to $1.7 billion; the trailing twelve-month figure through Dec 2014 stood at $1.7 billion (down 32.56% YoY), and the FY2014 full-year result was $1.7 billion, down 32.56% from the prior year.
• Current Deferred Tax Assets slipped to $1.7 billion in Q4 2014, from $2.5 billion in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $3.1 billion in Q4 2010 to a low of $1.7 billion in Q4 2014.
• A 5-year average of $2.6 billion and a median of $2.7 billion in 2011 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets surged 30.11% in 2010 and tumbled 32.56% in 2014, its largest moves.
• Tracing ABT's Current Deferred Tax Assets over 5 years: stood at $3.1 billion in 2010, then slipped by 12.19% to $2.7 billion in 2011, then advanced by 10.55% to $3.0 billion in 2012, then slipped by 15.34% to $2.5 billion in 2013, then plunged by 32.56% to $1.7 billion in 2014.
• Business Quant data shows ABT's Current Deferred Tax Assets at $1.7 billion in Q4 2014, $2.5 billion in Q4 2013, and $3.0 billion in Q4 2012.